ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence of Carbohydrate Intolerance in Lean and Obese Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00000112
Recruitment Status : Unknown
Verified December 2003 by National Center for Research Resources (NCRR).
Recruitment status was:  Recruiting
First Posted : January 19, 2000
Last Update Posted : June 24, 2005
Sponsor:
Information provided by:
National Center for Research Resources (NCRR)

Brief Summary:
The prevalence of obesity in children is reaching epidemic proportions. Excess adiposity is more than just a cosmetic problem, having substantial metabolic consequences. Insulin resistance, hyperinsulinemia, impaired glucose tolerance, and frank diabetes are often seen in obese children. In this study the prevalence of impaired glucose (carbohydrate) tolerance in lean children with a family history of diabetes and obese children with acanthosis nigricans with or without a family history of diabetes mellitus will be studied.

Condition or disease
Obesity Glucose Intolerance Diabetes Acanthosis Nigricans

Study Type : Observational
Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   8 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Obesity: BM +/- 95% for age general good health

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000112


Contacts
Contact: Sonia Caprio, M.D. 1-203-764-5692 sonia.caprio@yale.edu

Locations
United States, Connecticut
Yale University School of Medicine, Pediatric Endocrinology Recruiting
New Haven, Connecticut, United States, 06520-8064
Sponsors and Collaborators
National Center for Research Resources (NCRR)

ClinicalTrials.gov Identifier: NCT00000112     History of Changes
Other Study ID Numbers: NCRR-M01RR06022-0029
M01RR006022 ( U.S. NIH Grant/Contract )
First Posted: January 19, 2000    Key Record Dates
Last Update Posted: June 24, 2005
Last Verified: December 2003

Additional relevant MeSH terms:
Glucose Intolerance
Acanthosis Nigricans
Hyperglycemia
Glucose Metabolism Disorders
Metabolic Diseases
Melanosis
Hyperpigmentation
Pigmentation Disorders
Skin Diseases